Created at Source Raw Value Validated value
June 25, 2024, noon usa

* pregnancy and breastfeeding * hypersensitivity to colchicine * hypersensitivity to ruxolitinib * hypersensitivity to secukinumab * known liver failure * glomerular filtration rate \<20 ml/ min * physician judgment that the patient will need mechanical ventilation in 24 hours * qtc \> 450 ms * other indications for to colchicine, ruxolitinib, and secukinumab * chronic therapy with corticosteroids or immunosuppressive therapy * active cancer

* pregnancy and breastfeeding * hypersensitivity to colchicine * hypersensitivity to ruxolitinib * hypersensitivity to secukinumab * known liver failure * glomerular filtration rate \<20 ml/ min * physician judgment that the patient will need mechanical ventilation in 24 hours * qtc \> 450 ms * other indications for to colchicine, ruxolitinib, and secukinumab * chronic therapy with corticosteroids or immunosuppressive therapy * active cancer

Oct. 26, 2020, 11:31 p.m. usa

- pregnancy and breastfeeding - hypersensitivity to colchicine - hypersensitivity to ruxolitinib - hypersensitivity to secukinumab - known liver failure - glomerular filtration rate <20 ml/ min - physician judgment that the patient will need mechanical ventilation in 24 hours - qtc > 450 ms - other indications for to colchicine, ruxolitinib, and secukinumab - chronic therapy with corticosteroids or immunosuppressive therapy - active cancer

- pregnancy and breastfeeding - hypersensitivity to colchicine - hypersensitivity to ruxolitinib - hypersensitivity to secukinumab - known liver failure - glomerular filtration rate <20 ml/ min - physician judgment that the patient will need mechanical ventilation in 24 hours - qtc > 450 ms - other indications for to colchicine, ruxolitinib, and secukinumab - chronic therapy with corticosteroids or immunosuppressive therapy - active cancer